BiomarkersHumans

Serum β‐Synuclein as a Potential Early Biomarker for Alzheimer's Disease

AAIC 2025 Abstract

Abstract

Background: Alzheimer's disease (AD) is characterized by amyloid‐β (Aβ) plaques, neurofibrillary tangles, and synaptic dysfunction.

The paper

Xie S, Liang Y, Jia J et al.

AAIC 2025 Abstract · 25 Dec 2025 · CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70856_101498

Related